Market Indices


Latest News

Cowen & Co. analyst issues HOLD recommendation for JSPR on...

May 15, 2026   JSPR 4.23%

H.C. Wainwright analyst issues BUY recommendation for ELVA on May...

May 15, 2026   ELVA 5.78%

Boobalan Pachaiyappan from Roth Capital issued a price target of $38.00...

May 15, 2026   CAPR -1.71%

Roth Capital analyst issues BUY recommendation for CAPR on May...

May 14, 2026   CAPR -1.71%

Key Points
- Ondas stock (NASDAQ: ONDS) rises by 26.52% to...

May 14, 2026   ONDS 26.52%


Price Targets

Boobalan Pachaiyappan from Roth Capital issued a price target of $38.00 for CAPR on 2026-05-15 02:51:36.The adjusted price target was set to $38.00.At the time of the announcement,

May 15, 2026   CAPR -1.71%

from Craig-Hallum issued a price target of $7.00 for INVE on 2026-05-14 13:21:59.The adjusted price target was set to $7.00.At the time of the announcement, INVE was...

May 14, 2026   INVE -17.84%

from Roth Capital issued a price target of $7.00 for OVID on 2026-05-14 12:54:46.The adjusted price target was set to $7.00.At the time of the announcement, OVID...

May 14, 2026   OVID 0.00%

Boobalan Pachaiyappan from Roth Capital issued a price target of $19.00 for IMUX on 2026-05-14 12:51:02.The adjusted price target was set to $19.00.At the time of the announcement,

May 14, 2026   IMUX -2.28%

from Morgan Stanley issued a price target of $4.10 for ABSI on 2026-05-14 12:01:22.The adjusted price target was set to $4.10.At the time of the announcement, ABSI...

May 14, 2026   ABSI 4.53%



Market Movers

Top Gainers (%)
IPHA
Innate Pharma S.A.
2.17
64.39%
IPWR
Ideal Power Inc.
7.38
37.17%
FENC
Fennec Pharmaceuticals In
9.24
36.48%
ONDS
Ondas Holdings Inc.
11.21
26.52%
JSPRW
Jasper Therapeutics Inc
0.01
25.47%
DERM
Journey Medical Corporati
6.35
22.35%
RDW
Redwire Corporation
13.99
22.08%
QSIAW
Quantum-Si incorporated
0.05
20.92%

Annual/Quarterly Reports Summary

In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...

November 6, 2024   AIP 5.04%

In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...

November 6, 2024   EOSEW -34.96%

In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...

November 6, 2024   EOSE -1.33%

In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...

November 5, 2024   STOK -1.07%

In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...

November 5, 2024   BSVN 1.17%